Skip to content

Clinical trials

Neoplasms trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Not applicable Country / region: France Clear all

269 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20075
20082
20094
20105
20118
20127
201311
201416
201513
201612
201717
201820
201919
202020
202123
202214
202319
202417
202520
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Recruiting64
Unknown status34
Terminated22
Not yet recruiting11
Active, not recruiting6
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon20
Institut du Cancer de Montpellier - Val d'Aurelle18
Institut Curie14
Centre Leon Berard12
Assistance Publique - Hôpitaux de Paris11
Centre Antoine Lacassagne10
Centre Francois Baclesse10
Assistance Publique Hopitaux De Marseille9
Centre Hospitalier Universitaire de Saint Etienne7
Gustave Roussy, Cancer Campus, Grand Paris7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms269
Prostatic Neoplasms12
Breast Neoplasms11
Colorectal Neoplasms8
Lung Neoplasms8
COVID-197
Pain7
Sarcoma5
Carcinoma, Renal Cell4
Colonic Neoplasms4

Trials

Showing 1 to 25 of 269. Each trial links to its page on Pharma Observatory.

169 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.